Congenital melanocytic nevi: Where are we now?: Part II. Treatment options and approach to treatment

Omar A. Ibrahimi, Ali Alikhan, Daniel B Eisen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
Volume67
Issue number4
DOIs
StatePublished - Oct 2012

Fingerprint

Pigmented Nevus
Dermabrasion
Electrosurgery
Cryotherapy
Curettage
Cosmetics
Lasers
Radiotherapy
Therapeutics
Randomized Controlled Trials

Keywords

  • CMN
  • congenital melanocytic nevi
  • Er:YAG
  • erbium:yttrium-aluminum-garnet
  • GCMN
  • giant congenital melanocytic nevi
  • malignant melanoma
  • MM
  • Nd:YAG
  • neodymium-doped yttrium aluminum garnet
  • NMRL
  • normal-mode ruby laser
  • PAS
  • projected adult size
  • Q-switched ruby laser
  • QSRL

ASJC Scopus subject areas

  • Dermatology

Cite this

Congenital melanocytic nevi : Where are we now?: Part II. Treatment options and approach to treatment. / Ibrahimi, Omar A.; Alikhan, Ali; Eisen, Daniel B.

In: Journal of the American Academy of Dermatology, Vol. 67, No. 4, 10.2012.

Research output: Contribution to journalArticle

@article{853d4784812d4a488c39016a70dcf13a,
title = "Congenital melanocytic nevi: Where are we now?: Part II. Treatment options and approach to treatment",
abstract = "Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.",
keywords = "CMN, congenital melanocytic nevi, Er:YAG, erbium:yttrium-aluminum-garnet, GCMN, giant congenital melanocytic nevi, malignant melanoma, MM, Nd:YAG, neodymium-doped yttrium aluminum garnet, NMRL, normal-mode ruby laser, PAS, projected adult size, Q-switched ruby laser, QSRL",
author = "Ibrahimi, {Omar A.} and Ali Alikhan and Eisen, {Daniel B}",
year = "2012",
month = "10",
doi = "10.1016/j.jaad.2012.06.022",
language = "English (US)",
volume = "67",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Congenital melanocytic nevi

T2 - Where are we now?: Part II. Treatment options and approach to treatment

AU - Ibrahimi, Omar A.

AU - Alikhan, Ali

AU - Eisen, Daniel B

PY - 2012/10

Y1 - 2012/10

N2 - Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.

AB - Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.

KW - CMN

KW - congenital melanocytic nevi

KW - Er:YAG

KW - erbium:yttrium-aluminum-garnet

KW - GCMN

KW - giant congenital melanocytic nevi

KW - malignant melanoma

KW - MM

KW - Nd:YAG

KW - neodymium-doped yttrium aluminum garnet

KW - NMRL

KW - normal-mode ruby laser

KW - PAS

KW - projected adult size

KW - Q-switched ruby laser

KW - QSRL

UR - http://www.scopus.com/inward/record.url?scp=84866364330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866364330&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2012.06.022

DO - 10.1016/j.jaad.2012.06.022

M3 - Article

C2 - 22980259

AN - SCOPUS:84866364330

VL - 67

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -